|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5962406A
(en)
|
1991-10-25 |
1999-10-05 |
Immunex Corporation |
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
ES2156149T3
(es)
|
1992-12-04 |
2001-06-16 |
Medical Res Council |
Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US6410008B1
(en)
|
1994-12-12 |
2002-06-25 |
Beth Israel Hospital Association |
Chimeric IL-10 proteins and uses thereof
|
|
DE69534265T2
(de)
*
|
1994-12-12 |
2006-05-04 |
Beth Israel Deaconess Medical Center, Inc., Boston |
Chimäre zytokine und ihre verwendung
|
|
DE19605279A1
(de)
|
1996-02-13 |
1997-08-14 |
Hoechst Ag |
Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
|
US20010056075A1
(en)
|
1999-07-19 |
2001-12-27 |
Jeno Gyuris |
Chimeric polypeptides of serum albumin and uses related thereto
|
|
MXPA02001417A
(es)
|
1999-08-09 |
2002-08-12 |
Lexigen Pharm Corp |
Complejos multiples de citosina-anticuerpo.
|
|
US20020064531A1
(en)
|
2000-05-01 |
2002-05-30 |
Walker David H. |
Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
WO2003029462A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
WO2003029471A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of apolipoprotein d
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
|
WO2004082640A2
(en)
|
2003-03-19 |
2004-09-30 |
New Century Pharmaceuticals, Inc. |
Human serum albumin conjugates with therapeutic compounds
|
|
US7166577B2
(en)
|
2003-12-26 |
2007-01-23 |
Nipro Corporation |
Albumin having enhanced antimicrobial activity
|
|
JP4492156B2
(ja)
|
2004-03-03 |
2010-06-30 |
ニプロ株式会社 |
血清アルブミンドメインを含む蛋白質
|
|
TW200607523A
(en)
|
2004-06-01 |
2006-03-01 |
Domantis Ltd |
Drug compositions, fusions and conjugates
|
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
US7892827B2
(en)
|
2004-11-26 |
2011-02-22 |
Pieris Ag |
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
|
|
EP1745802A1
(en)
|
2005-07-20 |
2007-01-24 |
Kreatech Biotechnology B.V. |
Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes
|
|
WO2007061657A2
(en)
|
2005-11-14 |
2007-05-31 |
The Brigham & Women's Hospital, Inc. |
Interleukin-10 compositions for the treatment of adenocarcinomas
|
|
WO2007070660A2
(en)
|
2005-12-13 |
2007-06-21 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
|
WO2007079755A1
(en)
|
2006-01-12 |
2007-07-19 |
Janus Beierholm Holding Aps |
Reimmunization and antibody design
|
|
CN106008699A
(zh)
|
2006-09-08 |
2016-10-12 |
Ambrx公司 |
经修饰的人类血浆多肽或Fc骨架和其用途
|
|
WO2008033413A2
(en)
|
2006-09-14 |
2008-03-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
ES2623925T3
(es)
|
2007-05-30 |
2017-07-12 |
Postech Academy-Industry- Foundation |
Proteínas de fusión de inmunoglobulina
|
|
WO2009004339A2
(en)
*
|
2007-07-03 |
2009-01-08 |
Imperial Innovations Limited |
Compositions and methods relating to manipulation of the myeloid immune compartment during respiratory infection
|
|
GB0717985D0
(en)
|
2007-07-20 |
2007-10-24 |
Asterion Ltd |
Growth hormone fusion proteins
|
|
EP2190863B1
(en)
|
2007-07-31 |
2015-09-02 |
Affibody AB |
New albumin binding compositions, methods and uses
|
|
EP2535349A1
(en)
|
2007-09-26 |
2012-12-19 |
UCB Pharma S.A. |
Dual specificity antibody fusions
|
|
EP2352765B1
(en)
|
2008-10-01 |
2018-01-03 |
Amgen Research (Munich) GmbH |
Cross-species-specific single domain bispecific single chain antibody
|
|
NO2344540T3
(https=)
|
2008-10-02 |
2018-04-28 |
|
|
|
WO2010059315A1
(en)
|
2008-11-18 |
2010-05-27 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
|
KR101722961B1
(ko)
|
2009-02-11 |
2017-04-04 |
알부메딕스 에이/에스 |
알부민 변이체 및 접합체
|
|
JP5901517B2
(ja)
|
2009-05-28 |
2016-04-13 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
抗原結合性タンパク質
|
|
KR101286721B1
(ko)
|
2009-06-05 |
2013-07-16 |
한국과학기술연구원 |
폴리-시스테인 펩티드 융합 재조합 알부민 및 이의 제조방법
|
|
KR101074150B1
(ko)
|
2009-06-30 |
2011-10-17 |
(주) 굿맨프리미어파트너스 |
코코넛 맛 튀김용 새우 제조 방법
|
|
AU2010278702C1
(en)
|
2009-07-31 |
2016-07-14 |
Forsyth Dental Infirmary For Children |
Programming of cells for tolerogenic therapies
|
|
EP2493921B1
(en)
|
2009-10-30 |
2018-09-26 |
Albumedix Ltd |
Albumin variants
|
|
US8685406B2
(en)
|
2009-11-13 |
2014-04-01 |
The Board Of Regents Of The University Of Texas System |
Compositions of and method of using heat shock protein peptides
|
|
KR20130020765A
(ko)
|
2010-02-16 |
2013-02-28 |
메디뮨 엘엘씨 |
Ｈｓａ-관련 조성물 및 사용방법
|
|
JP2013520426A
(ja)
|
2010-02-18 |
2013-06-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｉｌ−２３に結合する、フィブロネクチンをベースとする足場ドメインタンパク質
|
|
EP2553101A4
(en)
|
2010-04-02 |
2013-09-04 |
Univ Rochester |
PROTEASE-ACTIVATED CYTOKINES
|
|
EP2556087A1
(en)
|
2010-04-09 |
2013-02-13 |
Novozymes Biopharma DK A/S |
Albumin derivatives and variants
|
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
CN103003296A
(zh)
|
2010-07-09 |
2013-03-27 |
阿菲博迪公司 |
多肽
|
|
AU2011316786A1
(en)
|
2010-10-22 |
2013-05-02 |
Protox Therapeutics Corp. |
Use of human serum albumin to decrease antigenicity of therapeutic proteins
|
|
PL2643349T3
(pl)
|
2010-11-26 |
2020-03-31 |
Molecular Partners Ag |
Zaprojektowane białka z powtórzeniami wiążące się z albuminą surowicy
|
|
CN103380143B
(zh)
|
2010-12-22 |
2016-01-06 |
百时美施贵宝公司 |
结合il-23的基于纤连蛋白的支架结构域蛋白质
|
|
EP2665486B1
(en)
|
2011-01-18 |
2019-12-25 |
Bioniz, LLC |
Compositions for modulating gamma-c-cytokine activity
|
|
MX341578B
(es)
|
2011-02-08 |
2016-08-25 |
Abbvie Inc |
Tratamiento de la osteoartritis y del dolor.
|
|
WO2012112690A2
(en)
*
|
2011-02-16 |
2012-08-23 |
Fabius Biotechnology |
Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains
|
|
AU2012222833B2
(en)
|
2011-03-03 |
2017-03-16 |
Zymeworks Inc. |
Multivalent heteromultimer scaffold design and constructs
|
|
CA2830660A1
(en)
|
2011-05-05 |
2012-11-08 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
|
BR112013029892A2
(pt)
|
2011-05-21 |
2016-12-20 |
Macrogenics Inc |
polipeptídeo, molécula de ligação a antígeno, diacorpo e uso de uma porção polipeptídica de uma proteína de ligação a soro desimunizada
|
|
EP2559441B1
(en)
|
2011-08-16 |
2021-07-21 |
Samsung Electronics Co., Ltd. |
Protein complex for intracellular delivery and uses thereof
|
|
EP2780364A2
(en)
|
2011-11-18 |
2014-09-24 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
|
EP2630971B8
(en)
|
2012-02-21 |
2017-12-13 |
Vergell Medical S.A. |
Combinations of albumin-based drug delivery systems
|
|
EP2820033A1
(en)
|
2012-02-29 |
2015-01-07 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates and their uses
|
|
CA2869748C
(en)
|
2012-04-12 |
2017-10-24 |
Yale University |
Vehicles for controlled delivery of different pharmaceutical agents
|
|
US11873281B2
(en)
|
2012-07-12 |
2024-01-16 |
Hangzhou Dac Biotech Co., Ltd. |
Conjugates of cell binding molecules with cytotoxic agents
|
|
WO2014012082A2
(en)
|
2012-07-13 |
2014-01-16 |
Zymeworks Inc. |
Multivalent heteromultimer scaffold design an constructs
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
CN105209074A
(zh)
|
2012-10-20 |
2015-12-30 |
得克萨斯大学体系董事会 |
癌细胞陷阱
|
|
MX2015005363A
(es)
|
2012-11-08 |
2015-11-06 |
Novozymes Biopharma Dk As |
Variantes de albumina.
|
|
US10526384B2
(en)
|
2012-11-19 |
2020-01-07 |
Pieris Pharmaceuticals Gmbh |
Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
|
|
EP2746396A1
(en)
|
2012-12-20 |
2014-06-25 |
PLS-Design GmbH |
Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
|
|
GB201223276D0
(en)
|
2012-12-21 |
2013-02-06 |
Ucb Pharma Sa |
Antibodies and methods of producing same
|
|
EP2752426A1
(en)
|
2013-01-03 |
2014-07-09 |
Covagen AG |
Human serum albumin binding compounds and fusion proteins thereof
|
|
CN105518143B
(zh)
|
2013-03-15 |
2020-02-21 |
北京凯得尔森生物技术有限公司 |
融合蛋白分子和它的使用方法
|
|
MX2015014438A
(es)
|
2013-04-18 |
2016-05-18 |
Armo Biosciences Inc |
Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
|
|
EP2988786A4
(en)
*
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
EP2989240A4
(en)
|
2013-04-24 |
2016-10-19 |
Armo Biosciences Inc |
INTERLEUKIN-10 COMPOSITIONS AND USES THEREOF
|
|
CN105658232A
(zh)
|
2013-08-30 |
2016-06-08 |
阿尔莫生物科技股份有限公司 |
使用白细胞介素-10治疗疾病和病症的方法
|
|
BR112016004355A2
(pt)
|
2013-08-30 |
2017-10-17 |
Aprilbio Co Ltd |
constructo de fusão de parte efetora de fab anti-soroalbumina e método de preparação do mesmo
|
|
CN115160441A
(zh)
|
2013-09-26 |
2022-10-11 |
埃博灵克斯股份有限公司 |
双特异性纳米抗体
|
|
CN105849124B
(zh)
|
2013-12-20 |
2022-04-12 |
豪夫迈·罗氏有限公司 |
双重特异性抗体
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
EP4707303A2
(en)
|
2014-05-16 |
2026-03-11 |
Ablynx NV |
Improved immunoglobulin variable domains
|
|
WO2015175957A1
(en)
|
2014-05-16 |
2015-11-19 |
Baylor Research Institute |
Methods and compositions for treating autoimmune and inflammatory conditions
|
|
WO2015187295A2
(en)
|
2014-06-02 |
2015-12-10 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
GB201413913D0
(en)
|
2014-08-06 |
2014-09-17 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
EP3194446B1
(en)
|
2014-09-18 |
2022-10-26 |
Cedars-Sinai Medical Center |
Compositions and methods for treating fibrosis
|
|
WO2016054107A1
(en)
|
2014-09-29 |
2016-04-07 |
Counterpoint Biomedica Llc |
Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polymers
|
|
US10016480B2
(en)
|
2014-10-14 |
2018-07-10 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Peptide-based methods for treating pancreatic cancer
|
|
AU2015336101A1
(en)
|
2014-10-22 |
2017-04-20 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
JP2018518945A
(ja)
|
2015-04-29 |
2018-07-19 |
メディオラヌム・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ |
可溶性キメラインターロイキン−１０受容体およびその療法使用
|
|
CN114920848B
(zh)
|
2015-05-13 |
2024-10-11 |
埃博灵克斯股份有限公司 |
基于cd3反应性的t细胞募集多肽
|
|
US20160361415A1
(en)
|
2015-05-28 |
2016-12-15 |
Armo Biosciences, Inc. |
Methods of Using Interleukin-10 for Treating Diseases and Disorders
|
|
HK1245671A1
(zh)
|
2015-05-29 |
2018-08-31 |
Armo Biosciences, Inc. |
使用白细胞介素-10治疗疾病和病症的方法
|
|
JP7007261B2
(ja)
|
2015-08-20 |
2022-01-24 |
アルブミディクス リミティド |
アルブミン変異体及びコンジュゲート
|
|
EP3356371A4
(en)
|
2015-09-29 |
2020-06-24 |
The University of Chicago |
POLYMER CONJUGATE VACCINE
|
|
WO2017062685A1
(en)
|
2015-10-09 |
2017-04-13 |
Bioniz, Llc |
Modulating gamma - c -cytokine activity
|
|
WO2017075136A1
(en)
|
2015-10-27 |
2017-05-04 |
Purdue Research Foundation |
Polymer-based therapeutics for inductive browning of fat
|
|
CN108350069B
(zh)
|
2015-10-30 |
2021-11-12 |
埃博灵克斯股份有限公司 |
针对il-23的多肽
|
|
KR101774150B1
(ko)
*
|
2016-04-08 |
2017-09-05 |
경희대학교 산학협력단 |
BSA(Bovine serum albumin)와 진세노사이드의 결합체 및 이의 용도
|
|
WO2017190074A1
(en)
|
2016-04-28 |
2017-11-02 |
The University Of Chicago |
Lymphangiogenesis for therapeutic immunomodulation
|
|
CA3022494A1
(en)
|
2016-05-01 |
2017-11-09 |
Ucb Biopharma Sprl |
Affinity engineered serum protein carrier binding domain
|
|
CN109562143A
(zh)
|
2016-05-06 |
2019-04-02 |
王牧林 |
白细胞介素组合及其用途
|
|
WO2017201731A1
(en)
|
2016-05-27 |
2017-11-30 |
Beijing Vdjbio Co., Ltd. |
Antibodies, composition and kits comprising same, and methods of use thereof
|
|
WO2017210684A1
(en)
|
2016-06-03 |
2017-12-07 |
New York University |
Methods and reagents for modulating macrophage phenotype
|
|
US10456423B2
(en)
|
2016-06-13 |
2019-10-29 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
WO2018005716A2
(en)
|
2016-07-01 |
2018-01-04 |
Denali Therapeutics Inc. |
Albumin variants for enhanced serum half-life
|
|
EP3481413A4
(en)
|
2016-07-08 |
2020-01-08 |
Askgene Pharma, Inc. |
FUSION PROTEIN WITH LEPTIN AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
CN106267191A
(zh)
|
2016-09-03 |
2017-01-04 |
山西纳安生物科技有限公司 |
纳米抗体生物药透皮给药制剂系统及制备方法和应用
|
|
BR112019005964A2
(pt)
|
2016-09-27 |
2019-06-18 |
Epicentrx, Inc. |
proteínas de fusão imunomoduladoras
|
|
US20200270322A1
(en)
*
|
2016-10-14 |
2020-08-27 |
Philogen S.P.A. |
Novel interleukin 4 immunoconjugates
|
|
CA3042867A1
(en)
|
2016-11-04 |
2018-05-11 |
Memorial Sloan Kettering Cancer Center |
Bi-specific activators for tumor therapy
|
|
CA3047312A1
(en)
*
|
2016-12-15 |
2018-06-21 |
The Brigham And Women's Hospital, Inc. |
Tissue-based biologics for the treatment of inflammatory and autoimmune disorders
|
|
US20190352335A1
(en)
|
2016-12-19 |
2019-11-21 |
Hanmi Pharm. Co., Ltd. |
Brain targeting long-acting protein conjugate
|
|
CN110545849A
(zh)
|
2017-02-03 |
2019-12-06 |
韩美药品株式会社 |
具有增加的持续性的生理活性物质的缀合物及其应用
|
|
HUE070957T2
(hu)
|
2017-02-16 |
2025-07-28 |
Sonnet Biotherapeutics Inc |
Albuminkötõ domén fúziós fehérjék
|
|
CA3054156A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
|
|
UY37651A
(es)
|
2017-03-31 |
2018-10-31 |
Swedish Orphan Biovitrum Ab Publ |
Polipéptido de unión al il-1r-i
|
|
WO2018184003A1
(en)
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Modulating dsrna editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon
|
|
KR20210122319A
(ko)
|
2017-04-06 |
2021-10-08 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
비스-링키지를 사용한 세포독성 약물의 접합
|
|
US11574747B2
(en)
|
2017-04-20 |
2023-02-07 |
The University Of Chicago |
Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies
|
|
JP7657548B2
(ja)
|
2017-04-21 |
2025-04-07 |
エランコ・ユーエス・インコーポレイテッド |
獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子
|
|
JP2020530280A
(ja)
|
2017-07-03 |
2020-10-22 |
トルク セラピューティクス， インコーポレイテッド |
免疫刺激性融合分子およびその使用
|
|
CN109553684A
(zh)
|
2017-09-25 |
2019-04-02 |
中国科学院过程工程研究所 |
一种纳米载体蛋白及其制备方法和应用
|
|
US11357861B2
(en)
|
2017-09-29 |
2022-06-14 |
Hanmi Pharm. Co., Ltd |
Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor
|
|
EP3694558B1
(en)
|
2017-10-10 |
2024-04-10 |
Medicenna Therapeutics Inc. |
Il-4-fusion formulations for treatment of central nervous system (cns) tumors
|
|
US20200353050A1
(en)
|
2017-11-10 |
2020-11-12 |
Armo Biosciences, Inc. |
Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors
|
|
US11732029B2
(en)
|
2017-11-13 |
2023-08-22 |
The University Chicago |
Methods and compositions for the treatment of wounds
|
|
EP3621652A4
(en)
|
2017-12-31 |
2021-01-13 |
Hangzhou DAC Biotech Co, Ltd |
CONJUGATE OF ANALOGUE OF TUBULYSIN WITH BRANCHED LINKS
|
|
AU2019232729B2
(en)
|
2018-03-05 |
2024-08-08 |
The University Of Chicago |
Methods and compositions for treating cancer with ECM-affinity peptides linked to cytokines
|
|
EP3762406A2
(en)
|
2018-03-09 |
2021-01-13 |
Askgene Pharma, Inc. |
Cytokine prodrugs
|
|
US20210171642A1
(en)
|
2018-03-26 |
2021-06-10 |
The University Of Chicago |
Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin)
|
|
EP3777894A4
(en)
|
2018-03-30 |
2022-04-06 |
Hanmi Pharm. Co., Ltd. |
ANTI-BRAIN DIRECTIONAL LONG-ACTING PROTEIN CONJUGATE, METHOD OF MANUFACTURE THEREOF AND COMPOSITION THEREOF
|
|
GB201805963D0
(en)
|
2018-04-11 |
2018-05-23 |
Avacta Life Sciences Ltd |
PD-L1 Binding Affirmers and Uses Related Thereto
|
|
CN110396133B
(zh)
|
2018-04-25 |
2021-07-23 |
免疫靶向有限公司 |
一种以白介素12为活性成分的融合蛋白型药物前体
|
|
EP3790577A4
(en)
|
2018-05-09 |
2022-04-27 |
The University of Chicago |
COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE
|
|
WO2019222296A1
(en)
|
2018-05-14 |
2019-11-21 |
Werewolf Therapeutics, Inc. |
Activatable interleukin 12 polypeptides and methods of use thereof
|
|
EP3806889A4
(en)
|
2018-06-18 |
2022-07-13 |
Anwita Biosciences, Inc. |
CYTOKI FUSION PROTEINS AND USES THEREOF
|
|
US20210221864A1
(en)
|
2018-08-24 |
2021-07-22 |
City Of Hope |
Masked cytokine conjugates
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
CN112955546B
(zh)
|
2018-11-26 |
2024-04-16 |
江苏恒瑞医药股份有限公司 |
一种人白细胞介素10变体及其衍生物
|
|
CN113710229B
(zh)
|
2019-02-25 |
2026-01-06 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|
|
CN113966221B
(zh)
|
2019-03-08 |
2026-03-31 |
麻省理工学院 |
合成溶瘤lnp复制子rna和用于癌症免疫治疗的用途
|
|
EP3969035A4
(en)
|
2019-05-14 |
2023-06-21 |
Werewolf Therapeutics, Inc. |
SEPARATION UNITS AND METHODS AND THEIR USE
|
|
WO2020247973A1
(en)
|
2019-06-03 |
2020-12-10 |
The University Of Chicago |
Methods and compositions for treating cancer with cancer-targeted adjuvants
|
|
WO2020263399A1
(en)
|
2019-06-26 |
2020-12-30 |
Massachusetts Institute Of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
BR112022001320A2
(pt)
|
2019-07-25 |
2022-04-12 |
Univ Chicago |
Composições e métodos compreendendo agentes terapêuticos ativados por protease
|
|
WO2021091986A1
(en)
|
2019-11-04 |
2021-05-14 |
Synthorx, Inc. |
Interleukin 10 conjugates and uses thereof
|
|
TW202128961A
(zh)
|
2019-11-20 |
2021-08-01 |
美商安維塔生物科學股份有限公司 |
細胞激素融合蛋白及其醫藥組合物及治療應用
|
|
IL293561A
(en)
|
2019-12-06 |
2022-08-01 |
Ablynx Nv |
Polypeptides comprising immunoglobulin with one variable domain targeting TNFa and IL-23
|
|
KR20210095781A
(ko)
|
2020-01-24 |
2021-08-03 |
주식회사 에이프릴바이오 |
항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
|
|
JP2023514152A
(ja)
|
2020-02-06 |
2023-04-05 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｉｌ－１０およびその使用
|